联合制药
Asciminib hydrochloride ………. 40mg.
Asciminib hydrochloride ………. 40mg.
Couldn't load pickup availability
manual
Asciminid Hydrochloride Tablets
【 Generic name 】 Asimini hydrochloride tablets
【 Brand name 】 ALIASSIMINI
【 Main ingredients 】 Asiminid...40mg.
【 Indications 】
This product is a kinase inhibitor suitable for the treatment of:
- Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP), previously treated with two or more tyrosine kinase inhibitors (TKls).
- Indicated for the treatment of chronic phase (CP) of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) with T315I mutation.
【 Usage and Dosage 】
- The recommended dose for Ph+ CML-CP patients is 80 mg once a day or 40 mg twice a day, approximately 12 hours apart.
- The recommended dose for patients with Ph+ CML-CP and T315I mutation is 200 mg twice a day, approximately 12 hours apart.
- Take orally without food, at least 2 hours before or 1 hour after taking.
- Treatment with IFNIL should continue as long as clinical benefit is observed or until unacceptable toxicity occurs.
【 Taboo 】
Patients who are allergic to the active ingredients or any excipients of this product.
- Myelosuppression: Severe events of thrombocytopenia and neutropenia may occur. Manage by interruption of treatment or dose reduction.
- Pancreatic toxicity: Monitor serum lipase and amylase.
- Hypersensitivity Reactions: May cause hypersensitivity reactions.
- Cardiovascular Toxicity: Cardiovascular toxicity may occur.
- Embryo-Fetal Toxicity: Can cause harm to the fetus.
[ Adverse Reactions ] Upper respiratory tract infection, musculoskeletal pain, decreased platelet count, increased triglycerides, decreased neutrophil count, increased uric acid, headache, fatigue, nausea, rash, and diarrhea.
【 Properties 】Purple-white tablets.
【 Validity period 】2 years from the date of production.
【 Packaging 】60 tablets/bottle.
【 Storage 】
- Store in airtight, moisture-proof place at room temperature between 20℃ and 25℃.
- Keep out of reach of children.
【 Manufacturer 】
Laos United Pharmaceutical Group Factory
Saysettha Development Zone, Vientiane, Lao People's Democratic Republic
Share
